41888-65-7

Basic information

• Product Name: 4-(3,4-dimethoxybenzylidene)-2-methyl-1,3-oxazol-5(4H)-one
• CAS NO: 41888-65-7
• Molecular Formula: C₁₃H₁₃NO₄
• Molecular Weight: 247.2466
• Mol File: 41888-65-7.mol
• Article Data: 17

Chemical Properties

• Boiling Point: 374.3°C at 760 mmHg
• Flash Point: 171.4°C
• Density: 1.21g/cm³
• Vapor Pressure: 8.41E-06mmHg at 25°C
• Refractive Index: 1.549
• CAS DataBase Reference: 4-(3,4-dimethoxybenzylidene)-2-methyl-1,3-oxazol-5(4H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3,4-dimethoxybenzylidene)-2-methyl-1,3-oxazol-5(4H)-one(41888-65-7)
• EPA Substance Registry System: 4-(3,4-dimethoxybenzylidene)-2-methyl-1,3-oxazol-5(4H)-one(41888-65-7)

Safety Data

• Hazardous Substances Data: 41888-65-7(Hazardous Substances Data)

Upstream product

• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 543-24-8 N-acetylglycine 
• 24474-93-9 2-methyl-4H-oxazol-5-one 

Downstream Products

• 138973-24-7 1,4-Bis(5'-(3,4-dimethoxybenzylidene)-2'-methyl-4'-imidazolinone-3'-ylamino)phthalazine 
• 72053-04-4 methyl 2-acetylamino-3-(3,4-dimethoxyphenyl)-2-propenoate 
• 143815-52-5 (Z)-3-(3,4-Dimethoxy-phenyl)-2-hydroxy-acrylic acid 
• 848150-55-0 (Z)-2-acetylamino-3-(3,4-dimethoxyphenyl)-N-methyl-2-propenamide 
• 188896-01-7 (Z)-3-(3,4-Dimethoxy-phenyl)-2-hydroxy-acrylic acid methyl ester 
• 870258-79-0 (R)-methyl 2-acetamido-3-(3,4-dimethoxyphenyl)propanoate 
• 78148-21-7 methyl (S)-2-acetamido-3-(3,4-dimethoxyphenyl)propanoate 
• 1357571-33-5 C₁₉H₁₈N₂O₃ 
• 75649-49-9 C₁₃H₁₅NO₅ 
• 28305-04-6 (S)-N-acetyl-3,4-dimethoxyphenylalanine 
• 33043-37-7 d-N-acetyl-3,4-dimethoxyphenylalanine 

Relevant articles and documents

Orthopalladation of GFP-Like Fluorophores Through C–H Bond Activation: Scope and Photophysical Properties

The luminescence of oxazolones R1-C6H4CH=CC(O)O-CN(R2) (1a–1j) and imidazolones R1-C6H4CH=CC(O)NR3CN(R2) (1k–1q) has been examined. The new GFP-like imidazo

New compounds having skin whitening, antioxidant and PPAR activity, and medical use thereof

PURPOSE: A novel compound with skin whitening, antioxidation, and PPAR activation effects, and a medical use thereof are provided to be used for a pharmaceutical composition or a cosmetic product. CONSTITUTION: A compound is denoted by chemical formula 1. A skin whitening composition contains the compound as an active ingredient. An antioxidative composition for preventing or treating oxidative diseases contains the compound of chemical formula 1 as an active ingredient. The oxidative diseases are selected among skin aging, pigmentation, wrinkling, psoriasis, or eczema. The composition prevents or treats diseases which are regulated by PPAR(peroxisome proliferator-activated receptor) activity. The PPAR includes PPAR alpha or PPAR gamma.

Asymmetric synthesis of unnatural amino acids and tamsulosin chiral intermediate

An efficient and enantioselective hydrogenation of N-acetylamino phenyl acrylic acids was successfully developed by using ruthenium catalyst. This methodology is important in the field of pharmaceuticals and provides a new process for the preparation of unnatural amino acids and tamsulosin chiral intermediate.